HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo.

AbstractBACKGROUND:
We have recently synthesized novel N-alkylated amino acid-derived hydroxamate, 2-[Benzyl-(2-nitro-benzenesulfonyl)-amino]-N-hydroxy-3-methyl-N-propyl-butyramide (NAHA). Here, we evaluate the anticancer activity of NAHA against highly invasive human breast cancer cells MDA-MB-231 in vitro and in vivo.
METHODOLOGY/PRINCIPAL FINDINGS:
Cell growth was evaluated by MTT and soft agar assays. Protein expression was determined by DNA microarray and Western blot analysis. Metastatic potential was evaluated by cell adhesion, migration, invasion, capillary morphogenesis, and ELISA assays. The anticancer activity in vivo was evaluated in mouse xenograft model. NAHA inhibited proliferation and colony formation of MDA-MB-231 cells together with the down-regulation of expression of Cdk2 and CDC20 proteins. NAHA inhibited cell adhesion, migration, and invasion through the suppression of secretion of uPA. NAHA suppressed secretion of VEGF from MDA-MB-231 cells and inhibited capillary morphogenesis of human aortic endothelial cells (HAECs). Finally, NAHA at 50 mg/kg was not toxic and decreased tumor volume and tumor weight in vivo. This suppression of tumor growth was associated with the inhibition of mitotic figures and induction of apoptosis, and the reduction of CD31 and VEGF positive cells in tumors.
CONCLUSION:
NAHA could be a novel promising compound for the development of new drugs for the therapy of invasive breast cancers.
AuthorsJiahua Jiang, Anita Thyagarajan-Sahu, Viktor Krchňák, Andrej Jedinak, George E Sandusky, Daniel Sliva
JournalPloS one (PLoS One) Vol. 7 Issue 3 Pg. e34283 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22479587 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-(benzyl-(2-nitrobenzenesulfonyl)amino)-N-hydroxy-3-methyl-N-propylbutyramide
  • Amides
  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Hydroxamic Acids
  • Vascular Endothelial Growth Factor A
  • butyramide
  • Valine
Topics
  • Amides (chemistry)
  • Angiogenesis Inhibitors (pharmacology)
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Breast Neoplasms (drug therapy)
  • Cell Line, Tumor
  • Cell Proliferation
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • Hydroxamic Acids (chemistry)
  • In Vitro Techniques
  • Mice
  • Mice, Nude
  • Models, Chemical
  • Neoplasm Invasiveness
  • Neoplasm Transplantation
  • Oligonucleotide Array Sequence Analysis
  • Valine (analogs & derivatives, chemistry)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: